Assignee
HYDRA BIOSCIENCES INC
US·25 granted patents·17 pending applications·119 citations·filing 2005–2018
Top patents by PatentIndex Score
42 records- 0194US8362025B2Compositions useful for treating disorders related to TRPA1HYDRA BIOSCIENCES INC·Filed 2009·Granted Jan 29, 2013·13 cites·10 claims
- 0294US7671061B2Methods and compositions for treating painHYDRA BIOSCIENCES INC·Filed 2006·Granted Mar 2, 2010·27 cites·8 claims
- 0393US9006207B2Compositions useful for treating disorders related to TRPA1HYDRA BIOSCIENCES INC·Filed 2013·Granted Apr 14, 2015·10 cites·10 claims
- 0492US7893260B2Substituted quinazolin-4-one compounds for antagonizing TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Feb 22, 2011·23 cites·13 claims
- 0591US7998980B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2007·Granted Aug 16, 2011·15 cites·10 claims
- 0689US7803790B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Sep 28, 2010·12 cites·10 claims
- 0788US9359359B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2014·Granted Jun 7, 2016·7 cites·21 claims
- 0884US9181219B2Compounds of modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2013·Granted Nov 10, 2015·5 cites·5 claims
- 0981US10221177B2Inhibiting the transient receptor potential A1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Granted Mar 5, 2019·3 cites·22 claims
- 1080US10399982B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2018·Granted Sep 3, 2019·1 cites·5 claims
- 1179US9969736B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2017·Granted May 15, 2018·1 cites·2 claims
- 1278US9815838B2Methods and compositions for treating painHYDRA BIOSCIENCES INC·Filed 2013·Granted Nov 14, 2017·2 cites·8 claims
- 1366US9951073B2Compounds and compositions for treating chemical warfare agent-induced injuriesHYDRA BIOSCIENCES INC·Filed 2012·Granted Apr 24, 2018·0 cites·2 claims
- 1464US2018265511A1Compounds and compositions for treating chemical warfare agent-induced injuriesHYDRA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1563US9732050B2Modulators of sperm hypermotility and uses thereofHYDRA BIOSCIENCES INC·Filed 2014·Granted Aug 15, 2017·0 cites·15 claims
- 1663US9505756B2Compounds useful for treating disorders related to TRPA1HYDRA BIOSCIENCES INC·Filed 2015·Granted Nov 29, 2016·0 cites·20 claims
- 1762US2018311248A1Compounds and compositions for treating chemical warfare agent-induced injuriesHYDRA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1861US8710052B2Compounds and compositions for treating chemical warfare agent-induced injuriesHYDRA BIOSCIENCES INC·Filed 2012·Granted Apr 29, 2014·0 cites·15 claims
- 1961US2009018147A1Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 2061US2018051020A1Compounds useful for treating disorders related to trpa1HYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2160US2016237089A1Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2259US8952041B2Modulators of sperm hypermobility and uses thereofHYDRA BIOSCIENCES INC·Filed 2012·Granted Feb 10, 2015·0 cites·6 claims
- 2358US9980968B2Compounds and compositions for treating chemical warfare agent-induced injuriesHYDRA BIOSCIENCES INC·Filed 2016·Granted May 29, 2018·0 cites·21 claims
- 2456US9895356B2Methods and compositions for treating anxietyHYDRA BIOSCIENCES INC·Filed 2015·Granted Feb 20, 2018·0 cites·17 claims
- 2556US2008311578A1System for screening eukaryotic membrane proteinsHYDRA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 2656US2014155417A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 2753US9649315B2Composition useful for treating disorders related to TRPA1HYDRA BIOSCIENCES INC·Filed 2015·Granted May 16, 2017·0 cites·10 claims
- 2853US2017151248A1Use of trpa1 antagonists to prevent or treat infections caused by biological-warfare agentsHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2953US2016256447A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 3052US2018133170A1Methods and compositions for treating disordersHYDRA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3151US2017224687A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3250US2017020858A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3348US2009226929A1Titinic ion channel, compositions and methods of useHYDRA BIOSCIENCES INC·Filed 2007·Application pending·0 cites
- 3448US2010273777A1Compounds for Modulating TRPV3 FunctionHYDRA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 3544US2016145257A1Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3640US2005261189A1Methods of promoting cardiac cell proliferationHYDRA BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 3736US9745272B2Quinazoline-2,4(1 H,3H)-dione derivativesHYDRA BIOSCIENCES INC·Filed 2015·Granted Aug 29, 2017·0 cites·11 claims
- 3836US9447114B2Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivativesHYDRA BIOSCIENCES INC·Filed 2015·Granted Sep 20, 2016·0 cites·15 claims
- 3936US9440972B2Pyrido[2,3-d]pyrimidine-2,4(1 H,3H)-dione derivativesHYDRA BIOSCIENCES INC·Filed 2015·Granted Sep 13, 2016·0 cites·16 claims
- 4036US9440973B2Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione derivativesHYDRA BIOSCIENCES INC·Filed 2015·Granted Sep 13, 2016·0 cites·16 claims
- 4136US2017050966A1Inhibiting the transient receptor potential a1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 4235US9440983B2Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione derivativesHYDRA BIOSCIENCES INC·Filed 2015·Granted Sep 13, 2016·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when HYDRA BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →